scorecardresearch
Add as a preferred source on Google
Monday, January 5, 2026
TopicCancer treatment

Topic: Cancer treatment

Combination of 2 immunotherapy drugs can help liver cancer patients live longer, finds India study

Done by researchers from Hyderabad's Asian Institute of Gastroenterology & Jaipur's Mahatma Gandhi Medical College, study was published in 'Journal of Clinical & Experimental Hepatology'.

Tata Memorial Centre-led project makes waves with promise to cut cancer drug costs by up to 99%

23 hospitals from National Cancer Grid, a network of over 250 cancer centres, pilot ‘pooled procurement’ to improve negotiability for high-value oncology and supportive-care drugs.

Key takeaway from Modi-Biden meet: India, US reiterate commitment to collaborative cancer research

As part of upcoming India-US Cancer Dialogue, both countries are planning to focus on advancing knowledge in cancer genomics, developing new diagnostics, therapeutics etc.

Tata Memorial now 1st govt facility in India to offer breakthrough ‘proton therapy’ for cancer

Starting this week, Mumbai’s Tata Memorial Centre will offer ‘proton beam therapy’, which allows more targeted treatment of cancerous tumours and fewer side-effects.

Founder of Mumbai firm behind new pan-cancer blood test says it can detect disease at ‘imminent’ stage

According to the makers, this test can detect cancerous stem cells before tumours form with 'nearly 100 per cent' accuracy.

On Camera

Trump is tying his legacy to whatever happens in Venezuela

A bad turn in Venezuela would raise the same questions that have dogged the unlawful US strikes against alleged drug boats in the Caribbean: Why now, and why at all?

Wall Street carries big expectations this year after best run since 2009

The concern is not that 2025’s rally was irrational, but that it may be difficult to repeat. Outlooks remain anchored to AI investment and growth without reigniting inflation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.